In a separate study, proteomic analysis of plasma and urine in patients with recurrent FSGS post transplantation reported apoA-I with a slightly higher molecular weight than authentic apoA-I, which differentiated recurrent FSGS from nonrecurrence [36]. The gene discussed is APOA1; the disease is focal segmental glomerulosclerosis.